Pulmonary Embolism Clinical Trials

Find Pulmonary Embolism Clinical Trials Near You

Repeated Examinations for Typing Pulmonary Embolism (RE-TyPE)

Status: Recruiting
Location: See all (3) locations...
Study Type: Observational
SUMMARY

PURPOSE The two related purposes of the RE-TyPE study are: 1. To improve understanding of the early clinical course of intermediate-high risk pulmonary embolism and its association with outcome and 2. To establish a platform for longitudinal follow-up for all pulmonary embolism at Sahlgrenska University Hospital HYPOTHESES 1. The dynamic pattern of change, evaluated thorough repeated measures of biomarkers, electrocardiography and echocardiography during the first 48 hours after pulmonary embolism, better predicts outcome than static measurements currently used to predict outcome 2. Establishment of a platform for longitudinal follow-up will improve quality of care and outcome for patients with pulmonary embolism at Sahlgrenska University Hospital

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Adult patients (≥ 18 years old) who is diagnosed with, or followed as out-patients for, PE at Sahlgrenska University Hospital

• Written informed consent

Locations
Other Locations
Sweden
Sahlgrenska University Hospital/Mölndal
NOT_YET_RECRUITING
Gothenburg
Sahlgrenska University Hospital/Östra
NOT_YET_RECRUITING
Gothenburg
Sahlgrenska University Hospital/Sahlgrenska
RECRUITING
Gothenburg
Contact Information
Primary
Rickard Zeijlon, MD, PhD
rickard.zeijlon@vgregion.se
+46313428884
Backup
Mazdak Tavoly, MD, PhD
+46313421000
Time Frame
Start Date: 2026-04-01
Estimated Completion Date: 2032-01-01
Participants
Target number of participants: 400
Treatments
Cohort A
Intermediate-high risk pulmonary embolism - prospective phenotyping thorugh serial investigations day 0, 1, 2 30 and 90.
Cohort B
All risk classes of pulmonary embolism - retrospective and prospective phenotyping at day 0, 90 (inclusion) and \>12 months (Cohorts overlap since all patients in Cohort A are also part of Cohort B)
Related Therapeutic Areas
Sponsors
Collaborators: Gothia Forum - Center for Clinical Trial
Leads: Sahlgrenska University Hospital

This content was sourced from clinicaltrials.gov